title: Preliminary results from a multidisciplinary university-based disease state management program focused on hypertension, hyperlipidemia, and diabetes.
abstract: OBJECTIVE
  To describe the implementation and evaluation of a pilot multidisciplinary disease state management (DSM) program for diabetes, hypertension, and hyperlipidemia at a private, self-insured university (over 900 covered lives).
  
  
  METHODS
  Enrollees met with a pharmacist, nurse, exercise physiologist, and students in these disciplines to improve clinical outcomes and fitness parameters. Clinical values, quality of life, patient knowledge of disease states, and patient satisfaction were assessed.
  
  
  RESULTS
  Of the 20 patients in the pilot program, 17 completed 1 nursing and 2 pharmacist visits; 8 completed exercise physiology visits. At baseline, elevated blood pressure readings were observed in 64.7% (11 of 17) of patients, 20% of those with diabetes (1 of 5) had an elevated hemoglobin A1c value (HbA1c), and 82.4% (14 of 17) had a cholesterol value that was not at goal. At least 1 medication-related problem was observed in 16 patients (94.1%). At 3 months, all patients with diabetes achieved HbA1c levels at or below 7%, 4 patients attained blood pressure control, and 1 achieved normal cholesterol readings. Patients characterized participation in the program as valuable and convenient.
  
  
  CONCLUSIONS
  Patients involved in the multidisciplinary DSM showed improved clinical outcomes after 3 months. Ongoing analysis of patient outcomes will determine the long-term effectiveness of the DSM.
authors: Department of Pharmacy Practice, Raabe College of Pharmacy, Ohio Northern University, OH 45810, USA. d-bright@onu.edu
authors: David R
authors: DR
authors: Bright
authors: Kelly R
authors: KR
authors: Kroustos
authors: Rhonda E
authors: RE
authors: Thompson
authors: Scott C
authors: SC
authors: Swanson
authors: Sara L
authors: SL
authors: Terrell
authors: Natalie A
authors: NA
authors: Dipietro
mesh_terms: D000328:Adult; D000368:Aged; D015415:Biomarkers / Q000097:blood; D001794:Blood Pressure; D002784:Cholesterol / Q000032:analysis; D003920:Diabetes Mellitus / Q000191:economics / Q000628:therapy*; D019468:Disease Management; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D006949:Hyperlipidemias / Q000191:economics / Q000628:therapy*; D006973:Hypertension / Q000191:economics / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010348:Patient Care Team; D017060:Patient Satisfaction; D010593:Pharmaceutical Services / Q000458:organization & administration*; D010595:Pharmacists / Q000458:organization & administration*; D010865:Pilot Projects; D011788:Quality of Life; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; D002784:Cholesterol; D006442:Glycated Hemoglobin